FDA OKs expanded use of Roche's Avastin for colon cancer treatment

01/23/2013 | American City Business Journals · Fox Business

The FDA authorized the use of Roche Holding's Avastin, or bevacizumab, with fluoropyrimidine-irinotecan or fluoropyrimidine-oxaliplatin chemotherapy, for patients with metastatic colorectal cancer whose condition worsened after previous treatment with the drug. Avastin was developed by Roche unit Genentech.

View Full Article in:

American City Business Journals · Fox Business

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations